Literature DB >> 2019116

Corneal graft survival in HLA-A- and HLA-B-matched transplantations in high-risk cases with retrospective review of HLA-DR compatibility.

W H Beekhuis1, G van Rij, J G Renardel de Lavalette, E Rinkel-van Driel, G Persijn, J D'Amaro.   

Abstract

In 107 HLA-A- and HLA-B-matched corneal transplantations performed in high-risk patients, the 3-year graft survival was 60.5%. The criteria used for the definition of high risk were vascularization of the recipient cornea and/or one or more previous failed grafts; they were also the indications for HLA typing and matching. Donor/recipient compatibility was defined by the presence of only 0 or 1 HLA-A or HLA-B mismatches. When non-immunological factors leading to graft failure were excluded, the 3-year survival was 76.3%. During that follow-up period, a total of 33 grafts failed; in 13 cases, the cause was allograft rejection. When only first transplants were considered, a 3-year graft survival of 81.0% was observed. Retrospective DR typing was possible in 33 cases. Because only three graft rejections occurred in that group, we were unable to assess the importance of DR compatibility on the survival of corneal allografts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019116

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

Review 1.  [Tissue typing in perforating corneal transplantation].

Authors:  J Wachtlin; R Khaireddin; F Hoffmann
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

Review 2.  [Typing for HLA matching. Advantages for keratoplasty].

Authors:  R Ignatius; F Hoffmann
Journal:  Ophthalmologe       Date:  2007-03       Impact factor: 1.059

3.  Cross-matches on donor cadaver retinal pigment epithelial cells in corneal risk patients.

Authors:  N Zavazava; B Nölle; G Duncker; S Jenisch; E Westphal; V Eckstein; W Müller-Ruchholtz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

4.  [Ranking of systemic steroids after normal-risk keratoplasty. Results of a randomized prospective study].

Authors:  S Mayweg; T Reinhard; H Spelsberg; A Reis; E Godehardt; R Sundmacher
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

5.  DNA-based HLA class II postmortem typing: evaluation of different techniques for prospective corneal allografting.

Authors:  S Jenisch; E Westphal; N Zavazava; C Dürr; G Duncker; B Nölle; W Müller-Ruchholtz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

Review 6.  Corneal Allografts: Factors for and against Acceptance.

Authors:  Justyna Sakowska; Paulina Glasner; Maciej Zieliński; Piotr Trzonkowski; Leopold Glasner
Journal:  J Immunol Res       Date:  2021-10-03       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.